文献速递生殖医学

高龄产妇单囊胚冷冻整倍体移植后体外受精与围产结局:供卵与自体卵周期的倾向性评分匹配分析

In vitro fertilization and perinatal outcomes of patients with advanced maternal age after single frozen euploid embryo transfer: a propensity score-matched analysis of autologous and donor cycles.
PubMed 文献 · Fertil Steril · 2024-06-03

这项多中心回顾性队列研究纳入39-46岁接受单囊胚冷冻整倍体移植的患者,供卵组与自体卵组各278例,经倾向性评分匹配后比较显示两组活产率、种植率、异位妊娠率、流产率、孕龄及出生体重均无统计学显著差异,提示高龄相关的生殖力下降主要由胚胎非整倍体驱动。

要点

  • 39-46岁患者单囊胚冷冻整倍体移植后,供卵组与自体卵组活产率无显著差异。
  • 两组种植率、异位妊娠率、流产率、孕龄及出生体重均无显著差异。
  • 作者认为高龄相关的IVF结局不良主要由胚胎非整倍体驱动。

核心结论

  • 供卵或自体卵来源的整倍体囊胚移植后,活产率、种植率、异位妊娠率、流产率、孕龄及婴儿出生体重均无统计学显著差异。
  • 作者认为高龄女性的年龄相关生殖力下降和/或IVF结局不良主要由胚胎非整倍体驱动。

研究设计与样本

  • 多中心回顾性队列研究,设置于大学附属及私立IVF中心。
  • 纳入2017年10月至2021年10月期间接受ICSI及全染色体测序PGT-A的39-46岁患者,供卵组278例、自体卵组278例。
  • 干预为供卵或自体卵来源的单囊胚冷冻整倍体移植。

主要发现

  • 供卵组与自体卵组种植率分别为57.91%(51.87-63.78)与57.19%(51.15-63.09),无显著差异。
  • 供卵组与自体卵组活产率分别为41.01%(95%CI 35.17-47.04)与42.45%(95%CI 36.56-48.49),无显著差异。
  • 供卵组与自体卵组异位妊娠率分别为0.72%(0.09-2.57)与0.36%(0.01-1.99),流产率分别为16.19%(12.06-21.05)与14.39%(95%CI 10.48-19.08),均无显著差异。
  • 供卵组与自体卵组孕龄分别为38.50(38.08-38.92)周与39.16(38.25-40.07)周,出生体重分别为2,982.25(2,606.69-3,357.81)kg与3,128.24(2,962.30-3,294.17)kg,均无显著差异。
  • 单因素分析显示高龄与活产率无关联(相对风险1.03,95%CI 0.84-1.25);多因素分析校正胚胎潜能相关混杂因素后亦无关联(校正相对风险1.22,95%CI 0.75-1.98)。

关键数值与推荐

  • 主要结局为首次胚胎移植后的活产率,按每移植周期计算。
  • 次要结局包括种植率、异位妊娠率、流产率及分娩时孕龄和出生体重。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate in vitro fertilization (IVF) and perinatal outcomes of donor egg and autologous cycles in patients with advanced reproductive age after undergoing single frozen euploid embryo transfer. DESIGN: A multicenter, retrospective, cohort study. SETTING: University-affiliated and private IVF centers. PATIENT(S): Patients aged 39-46 years who underwent IVF with intracytoplasmic sperm injection and preimplantation genetic testing for aneuploidy using whole-chromosome sequencing with donor (n = 278) or autologous (n = 278) oocytes between October 2017 and October 2021. INTERVENTION(S): Single frozen euploid embryo transfer with donor or autologous euploid embryo. MAIN OUTCOME MEASURE(S): The main outcome measure was the live birth rate (LBR) after the first embryo transfer, calculated per embryo transfer. The secondary outcomes included the implantation rate, ectopic pregnancy rate, miscarriage rate, and gestational age and birth weight at the time of delivery. RESULT(S): Patients using donor or autologous oocytes had a similar likelihood of implantation (57.91% [51.87-63.78] vs. 57.19% [51.15-63.09]) and LBR (41.01% [95% confidence interval {CI}, 35.17-47.04] vs. 42.45% [95% CI, 36.56-48.49]). Furthermore, there were no significant differences in the ectopic pregnancy rate (0.72% [0.09-2.57] vs. 0.36% [0.01-1.99]), miscarriage rate (16.19% [12.06-21.05] vs. 14.39% [95% CI, 10.48-19.08]), gestational age (38.50 [38.08-38.92] vs. 39.16 [38.25-40.07] weeks), or birth weight of infants (2,982.25 [2,606.69-3,357.81] vs. 3,128.24 [2,962.30-3,294.17] kg). The univariate analysis showed no association between advanced maternal age and the LBR (relative risk, 1.03 [95% CI, 0.84-1.25]). Multivariate analysis using putative confounders for embryo competency found no associations with LBR (adjusted relative risk, 1.22 [95% CI, 0.75-1.98]). CONCLUSION(S): Patients with euploid blastocysts derived from donor or autologous oocytes did not reveal statistically significant differences in the LBR, implantation rate, ectopic pregnancy rate, miscarriage rate, duration of gestation, or infant birth weight. These findings suggest that age-related reproductive decline and/or poor IVF outcomes associated with women with advanced reproductive age undergoing IVF are heavily driven by embryonic aneuploidy.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Cozzolino M, Capalbo A, Garcia-Velasco JA, et al. In vitro fertilization and perinatal outcomes of patients with advanced maternal age after single frozen euploid embryo transfer: a propensity score-matched analysis of autologous and donor cycles. Fertil Steril. 2024. PMID: 38838805. doi:10.1016/j.fertnstert.2024.05.170

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。